14 Results for "

CYP11B1

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "CYP11B1" in MCE Product Catalog:

  • Categories Recommended:
    More
4
4 Cited Publications
Cat. No.: HY-16276
CAS No.: 928134-65-0
Synonyms: LCI699
Osilodrostat (LCI699) is a potent, orally active11β-hydroxylase (CYP11B1) inhibitor with an IC50 value of 35 nM. Osilodrostat is a potent, orally aldosterone synthase (CYP11B2) inhibitor with IC50 values of 0.7 nM and 160 nM for human aldosterone synthase and rat aldosterone synthase, respectively. Osilodrostat inhibits aldosterone and corticosterone synthesis. Osilodrostat has blood pressure lowering ability. Osilodrostat can be used for research of Cushing syndrome (CS) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-16276A
CAS No.: 1315449-72-9
Synonyms: LCI699 phosphate
Research Areas:  

Cardiovascular Disease Cancer

Osilodrostat (LCI699) phosphate is a potent, orally active11β-hydroxylase (CYP11B1) inhibitor with an IC50 value of 35 nM. Osilodrostat phosphate is a potent, orally aldosterone synthase (CYP11B2) inhibitor with IC50 values of 0.7 nM and 160 nM for human aldosterone synthase and rat aldosterone synthase, respectively. Osilodrostat phosphate inhibits aldosterone and corticosterone synthesis. Osilodrostat phosphate has blood pressure lowering ability. Osilodrostat phosphate can be used for research of Cushing syndrome (CS) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0105B
CAS No.: 142128-57-2
Synonyms: (-)-Ketoconazole; (-)-Ketoconazol; (-)-R 41400
Target:  

Cytochrome P450

Research Areas:  

Infection Inflammation/Immunology

Levoketoconazole ((-)-Ketoconazole) is the 2S,4R enantiomer derived from racemic Ketoconazole (HY-B0105). Levoketoconazole is a potent and orally active cortisol synthesis inhibitor. Levoketoconazole inhibits key steps in cortisol and testosterone synthesis by inhibiting CYP11B1, CYP11A1, and CYP17A1. Levoketoconazole can be used for research on endogenous Cushing’s syndrome .
loading...
    loading...
Cat. No.: HY-101217
CAS No.: 1633009-87-6
Purity:  99.20%
Target:  

Cytochrome P450

Research Areas:  

Endocrinology

BI 689648 is a novel, highly selective aldosterone synthase inhibitor which can inhibit CYP11B1 and CYP11B2 with IC50s of 310 and 2.1 nM, respectively.
loading...
    loading...
Cat. No.: HY-RS17315
Research Areas:  

Others

Cyp11b1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cyp11b1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS03435
Research Areas:  

Others

CYP11B1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP11B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-151140
CAS No.: 3031098-46-8
Target:  

Cytochrome P450

Research Areas:  

Others

CYP11B1-IN-2 (compound 7aa) is an orally active, potent and selective CYP11B1 inhibitor, with IC50 values of 9 nM and 25 nM for human CYP11B1 and rat CYP11B1, respectively. CYP11B1-IN-2 can be used for the research of diseases caused by excessive cortisol .
loading...
    loading...
Cat. No.: HY-RS23770
Research Areas:  

Others

Cyp11b1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cyp11b1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-135281
CAS No.: 1356479-78-1
Purity:  99.83%
Target:  

Cytochrome P450

Research Areas:  

Cardiovascular Disease

CYP11B2-IN-1 is a CYP11B2 inhibitor with an IC50 of 2.3 nM. CYP11B2-IN-1 inhibits CYP11B1 with an IC50 of 142 nM .
loading...
    loading...
Cat. No.: HY-122744
CAS No.: 2101952-78-5
Target:  

Cytochrome P450

Research Areas:  

Metabolic Disease Cancer

CYP11B1-IN-1 is a selective, orally active hCYP11B1 inhibitor, with an IC50 of 2 nM against hCYP11B1 and an IC50 of 1.8 μM against rat CYP11B1. CYP11B1-IN-1 can be used for the research of Cushing's disease .
loading...
    loading...
Cat. No.: HY-163751
Research Areas:  

Metabolic Disease

STING-IN-9 (compound 2) is a potent inhibitor of human CYP11B2. STING-IN-9 showed more than 80 times higher selectivity over human CYP11B1 in vitro .
loading...
    loading...
Cat. No.: HY-176480
CAS No.: 3072732-90-9
Target:  

Cytochrome P450

Research Areas:  

Cardiovascular Disease

CYP11B2-IN-3 (compound 32) is an orally active and selective CYP11B2 inhibitor with IC50 values of 12.92 nM and 2341 nM for CYP11B2 and CYP11B1, respectively. CYP11B2-IN-3 can be used for study of hypertension .
loading...
    loading...
Cat. No.: HY-16276R
CAS No.: 928134-65-0
Synonyms: LCI699 (Standard)
Osilodrostat (Standard) is the analytical standard of Osilodrostat. This product is intended for research and analytical applications. Osilodrostat (LCI699) is a potent, orally active11β-hydroxylase (CYP11B1) inhibitor with an IC50 value of 35 nM. Osilodrostat is a potent, orally aldosterone synthase (CYP11B2) inhibitor with IC50 values of 0.7 nM and 160 nM for human aldosterone synthase and rat aldosterone synthase, respectively. Osilodrostat inhibits aldosterone and corticosterone synthesis. Osilodrostat has blood pressure lowering ability. Osilodrostat can be used for research of Cushing syndrome (CS) .
loading...
    loading...
Cat. No.: HY-101217R
CAS No.: 1633009-87-6
Research Areas:  

Endocrinology

BI 689648 (Standard) is the analytical standard of BI 689648 (HY-101217). This product is intended for research and analytical applications. BI 689648 is a novel, highly selective aldosterone synthase inhibitor which can inhibit CYP11B1 and CYP11B2 with IC50s of 310 and 2.1 nM, respectively.
loading...
    loading...
  • 1